Regulations.gov document
Luitpold Pharmaceuticals, Inc. (Sheppard Mullin Richter & Hampton LLP) - Supplement
Other · FDA-2005-P-0319 · posted Mar 18, 2011
Key facts
| Document ID | FDA-2005-P-0319-0019 |
|---|---|
| Title | Luitpold Pharmaceuticals, Inc. (Sheppard Mullin Richter & Hampton LLP) - Supplement |
| Document type | Other |
| Subtype | SUP-Supplement |
| Agency | FDA |
| Docket | FDA-2005-P-0319 |
| Posted | Mar 18, 2011 |
| Comment period opens | Mar 18, 2011 |
At a glance
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: